Patent classifications
G01N33/56966
CD8+T-CELL SUBSETS AS MARKERS FOR PREDICTION OF DELAYED FRACTURE HEALING
The present invention relates to a method for diagnosis of delayed bone fracture healing, comprising determining the frequency of a subpopulation of CD8+ cells selected from a first group comprised of CD8+CD57+, CD8+CD28 and CD8+CD28/CD57+, in a sample obtained from a subject. The present invention further relates to a system and a kit of parts for prediction and resulting options for preventing of delayed bone fracture healing.
RAPID REAL TIME MULTIPOINT PROCEDURE FOR OPTIMIZING SPERM STATE FOR USE IN ASSISTED REPRODUCTIVE TECHNOLOGIES
A method for adjusting the maturation state of mammalian sperm for use in assisted reproductive technologies (ART) is disclosed. A mammalian ejaculate is provided and incubated under controlled conditions. Aliquots of the ejaculate are assayed during incubation period at intervals to determine maturation state and changes in the maturation state by observing the percent positive cells in the aliquot. The assays are repeated with successive aliquots at intervals during incubation to observe real time changes in the maturation state. The ejaculate remaining is processed for the desired ART after the percentage of positive cells in the latest aliquot being assayed begins to decline.
Use of Tumor Dissociation Reagent in Flow Cytometry
The present disclosure relates to a dissociation reagent for tumor tissues. The dissociation reagent does not contain collagenase or trypsin but further contains hyaluronidase or a mixture of hyaluronidase and DNase I. The present disclosure also relates to use of the dissociation reagent in dispersing tumor tissues and detecting expression level of molecular markers on cell surface by flow cytometry. The dissociation reagent of the present disclosure does not cause degradation of molecular markers on cell surface such as CD8, PD-1, Tim-3, Lag-3 and the like, thus does not affect downstream assays.
COMPOSITIONS AND METHODS FOR PROGRAMMABLE SENSING AND CONTROL THROUGH COMBINATORIAL MOLECULAR INTERACTIONS
Methods and compositions are provided for the selective activation of a BMP-dependent response in certain cell types. Methods include identifying a ligand or ligand combinations as well as cell receptor profiles that result in selectively activating a ligand-dependent response through interactions with ligand receptors on a first cell type that do not activate the ligand-dependent response in a second cell type.
SYSTEMS AND METHODS FOR TREATING AND CONDITIONING SMALL VOLUME LIQUID SAMPLES
Systems and methods are for creating liquid toroidal mixing patterns within microliter volumes of liquids are contemplated. An electrode geometry comprising peripheral electrodes defining an annular configuration and interior electrodes are contemplated, to which an alternating current may be applied. Via control of the frequency, waveform, amplitude and bias of the current, liquids and the components of those liquids may be mixed in a toroidal motion. This same electrode geometry may also be used to accomplish the deposition of targeted materials onto the surface of the peripheral or interior electrode by further manipulating the frequency, amplitude, and bias of the waveform of the applied current. Methods of applying such techniques are also contemplated in the context of blood typing assays, latex agglutination assays, micro array assays, transfection, transduction, and tissue engineering methods, and it may be seen that such techniques may result in substantial benefits.
METHODS FOR CELL PROLIFERATION AND TOXICITY TESTING
Provided herein are methods and devices for measuring and monitoring proliferation and toxicity in vitro.
IMAGE ANALYSIS AND MEASUREMENT OF BIOLOGICAL SAMPLES
Methods, devices, systems, and apparatuses are provided for the image analysis of measurement of biological samples.
RENAL CELL POPULATIONS AND USES THEREOF
The present invention concerns enriched heterogeneous mammalian renal cell populations characterized by biomarkers, and methods of making and using the same.
COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PATHOLOGICAL FIBROBLAST CELLS
Compositions, kits and methods for assessing the presence of pathological fibroblasts within a biological sample are provided. In addition, compositions, kits and methods for detecting fibrosis are provided. Also provided are methods for treating fibrosis and conditions characterized with pathological fibroblasts.
ANTIDOTE-MEDIATED REVERSAL OF EXTRACELLULAR APTAMER STAINING
Provided herein are compositions and methods for sorting and/or identifying live cells. The compositions and methods provide for staining of live cells with aptamer so particular cells can be identified within or sorted from a heterogeneous population of live cells and subsequent reversal of the staining to prepare sorted and/or identified cells in their native state.